Yüklüyor......
The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study
BACKGROUND: The Drugs for Neglected Diseases initiative (DNDi) is a not-for profit organization committed to providing affordable medicines and access to treatments in resource-poor settings. Traditionally drug development has happened “in house” within pharmaceutical companies, with research and de...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3640935/ https://ncbi.nlm.nih.gov/pubmed/23433060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-68 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|